Harmonizing the diagnosis of metabolic syndrome - Focusing on abdominal obesity

Metabolic Syndrome and Related Disorders

Volumn 11, Issue 2, 2013, Pages 102-108

  Silva, Valter ^a,b   Stanton, Kenneth R ^c   Grande, Antonio José ^a,b  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b CCBS   (Brazil)

^c Criminal Justice and Applied Social and Political Sciences Department   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMINAL OBESITY; ADOLESCENT; ADULT; ARTICLE; CHILD; DIAGNOSTIC REASONING; ETHNICITY; HUMAN; METABOLIC SYNDROME X; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY; WAIST CIRCUMFERENCE; WAIST HIP RATIO;

ANTHROPOMETRY; BODY MASS INDEX; HUMANS; INTERNAL MEDICINE; METABOLIC SYNDROME X; OBESITY; OBESITY, ABDOMINAL; RISK FACTORS; WAIST CIRCUMFERENCE; WORLD HEALTH;

EID: 84876786525     PISSN: 15404196     EISSN: 15578518     Source Type: Journal    
DOI: 10.1089/met.2012.0060     Document Type: Article

References (69)

1. Enzi G, Busetto L, Inelmen EM, et al. Historical perspective: Visceral obesity and related comorbidity in Joannes Baptista Morgagni's 'De Sedibus et Causis Morborum per Anatomen Indagata'. Int J Obes 2003;27:534-535. (Pubitemid 36520855)
2. Alberti KGMM, Zimmet P, Shaw J. Metabolic syndrome - a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med 2006;23: 469-480.
3. Vague J. The degree of masculine differentiation of obesities: A factor determining predisposition to diabetes, atherosclerosis, gout, and uric calculous disease. Am J Clin Nutr 1956; 4:20-34.
4. Reaven G. Role of insulin resistance in human disease. Diabetes 1988;37:1595-607. (Pubitemid 19004941)
5. Kaplan NM. The deadly quartet. Upper-body obesity, glucose intolerance, hypertriglyceridemia, and hypertension. Arch Intern Med 1989;149:1514-1520. (Pubitemid 19177621)
6. Alberti KGMM, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications, part 1: Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998;15:539-553. (Pubitemid 28319935)
7. World Health Organization. Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications. Report of a WHO consultation. Geneva: World Health Organization, 1999.
8. Alberti KGMM, Zimmet P, Shaw J; IDF Epidemiology Task Force Consensus Group. The metabolic syndrome: A new worldwide definition. Lancet 2005;366:1059-1062. (Pubitemid 41338752)
9. Balkau B, Charles MA. Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR). Diabet Med 1999;16:442-443.
10. Einhorn D, Reaven GM, Cobin RH, et al. American College of Endocrinology position statement on the insulin resistance syndrome. Endocr Pract 2003;9:237-252.
11. Grundy SM, Cleeman JI, Daniels SR, et al.; American Heart Association; National Heart, Lung, and Blood Institute. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement [published corrections appear in Circulation 2005; 112:e297
12. and Circulation 2005;112:e298].
13. Circulation 2005;112:2735-2752.
14. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Final report. Circulation 2002;106:3143-3421.
15. Alberti KG, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome: A joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009;120: 1640-1645.
16. Allison DB, Downey M, Atkinson RL, et al. Obesity as a disease: A white paper on evidence and arguments commissioned by the Council of The Obesity Society. Obesity 2008;16:1161-1177. (Pubitemid 351770522)
17. Silva V, Stanton KR, Almeida PBL, et al. Central obesity and not BMI as a universal criterion of obesity for predicting morbimortality risk [Letter]. J Clin Endocrinol Metab 2010;95: 1777-1778.
18. Obesity: Preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser 2000;894:i-xii, 1-253.
19. National Institutes of Health. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: The evidence report [published correction appears in Obes Res 1998;6:464].
20. Obes Res 1998;6(Suppl 2):51S-209S.
21. Health Canada. Canadian Guidelines for Body Weight Classification in Adults. Ottawa, Canada: Health Canada Publications Centre; 2003. Publication ID No. 4645. ISBN 0-662-33431-0.
22. Khan NA, McAlister FA, Rabkin SW, et al; Canadian Hypertension Education Program. The 2006 Canadian Hypertension Education Program recommendations for the management of hypertension, part II: Therapy. Can J Cardiol 2006;22:583-593. (Pubitemid 44044214)
23. Graham I, Atar D, Borch-Johnsen K, et al.; ESC Committee for Practice Guidelines. European guidelines on cardiovascular disease prevention in clinical practice: Executive summary. Atherosclerosis 2007;194:1-45. (Pubitemid 47470068)
24. Han TS, van Leer EM, Seidell JC, et al. Waist circumference action levels in the identification of cardiovascular risk factors: Prevalence study in a random sample. BMJ 1995; 311:1401-1405.
25. Lean MEJ, Han TS, Morrison CE. Waist circumference as a measure for indicating need for weight management. BMJ 1995;311:158-161.
26. Pitanga FJ, Lessa I. Anthropometric indexes of obesity as an instrument of screening for high coronary risk in adults in the city of Salvador-Bahia. Arq Bras Cardiol 2005;85:26-31. (Pubitemid 41025802)
27. Janssen I, Katzmarzyk PT, Ross R. Waist circumference and not body mass index explains obesity related health risk. Am J Clin Nutr 2004;79:379-384. (Pubitemid 41115579)
28. Yusuf S, Hawken S, Ôunpuu S, et al., on behalf of the IN-TERHEART Study Investigators. Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: A case-control study. Lancet 2005;366:1640-1649. (Pubitemid 41552419)
29. Dalton M, Cameron AJ, Zimmet PZ, et al. Waist circumference, waist-hip ratio and body mass index and their correlation with cardiovascular disease risk factors in Australian adults. J Intern Med 2003;254:555-563. (Pubitemid 37521852)
30. Balkau B, Deanfield JE, Després JP, et al. International day for the evaluation of abdominal obesity (IDEA): A study of waist circumference, cardiovascular disease, and diabetes mellitus in 168,000 primary care patients in 63 countries. Circulation 2007;116:1942-1951. (Pubitemid 350287090)
31. World Health Organisation, International Association for the Study of Obesity, International Obesity TaskForce. The Asia-Pacific Perspective: Redefining obesity and its treatment. Sydney: Health Communications, 2000.
32. Ko GT, Chan JC, Cockram CS, et al. Prediction of hypertension, diabetes, dyslipidaemia or albuminuria using simple anthropometric indexes in Hong Kong Chinese. Int J Obes Relat Metab Disord 1999;23:1136-1142.
33. McKeigue PM, Shah B, Marmot MG. Relation of central obesity and insulin resistance with high diabetes prevalence and cardiovascular risk in South Asians. Lancet 1991;337: 382-86.
34. Alves-Silva J, Santos MS, Guimarães PE, et al. The ancestry of Brazilian mtDNA lineages [published correction appears in Am J Hum Genet 2000;67:775]. Am J Hum Genet 2000; 67:444-461.
35. Ross R, Berentzen T, Bradshaw AJ, et al. Does the relationship between waist circumference, morbidity and mortality depend on measurement protocol for waist circumference? Obes Rev 2008;9:312-325. (Pubitemid 351842189)
36. Silva V, Rodrigues D, Guiseline M, et al. The diagnosis of abdominal obesity is affected by the measurement site [Abstract]. Med Sci Sports Exerc 2010;42(Suppl 5):S470.
37. Pischon T, Boeing H, Hoffmann K, et al. General and abdominal adiposity and risk of death in Europe. N Engl J Med 2008;359:2105-2120.
38. Erratum in N Engl J Med 2010; 362:2433.
39. Grundy SM, Adams-Huet B, Vega GL. Variable contributions of fat content and distribution to metabolic syndrome risk factors. Metab Syndr Relat Disord 2008;6:281-288.
40. Marfell-Jones M, Olds T, Stewart A, Carter L. International Standards for Anthropometric Assessment. Potchefstroom, South Africa: ISAK, 2006.
41. Wang ZM, Pierson RN Jr, Heymsfield SB. The five-level model: A new approach to organizing body-composition research. Am J Clin Nutr 1992;56:19-28.
42. Hamdy O, Porramatikul S, Al-Ozairi E. Metabolic obesity: The paradox between visceral and subcutaneous fat. Curr Diabetes Rev 2006;2:367-373. (Pubitemid 44734225)
43. Janssen I, Heymsfield SB, Allison DB, et al. Body mass index and waist circumference independently contribute to the prediction of nonabdominal, abdominal subcutaneous, and visceral fat. Am J Clin Nutr 2002;75:683-688. (Pubitemid 34250681)
44. Becker MC, Galla JM, Nissen SE. Left main trunk coronary artery dissection as a consequence of inaccurate coronary computed tomographic angiography. Arch Intern Med 2011; 11;171:698-701.
45. Moynihan R, Doust J, Henry D. Preventing overdiagnosis: How to stop harming the healthy. BMJ 2012;344:e3502.
46. Sénéchal M, Bouchard DR, Dionne IJ, et al. Lifestyle habits and physical capacity in patients with moderate or severe metabolic syndrome. Metab Syndr Relat Disord 2012;10: 232-240.
47. Yu SSK, Castillo DC, Courville AB, et al. The triglyceride paradox in people of African descent. Metab Syndr Relat Disord 2012;10:77-82.
48. Jialal I. The tenth anniversary of Metabolic Syndrome and Related Disorders. Metab Syndr Relat Disord 2012;10:1-2. (Pubitemid 46641417)
49. Hari P, Nerusu K, Veeranna V, et al. A gender-stratified comparative analysis of various definitions of metabolic syndrome and cardiovascular risk in a multiethnic U.S. population. Metab Syndr Relat Disord 2012;10:47-55.
50. Salazar MR, Espeche WG, March CE, et al. Optimal uric acid threshold to identify insulin resistance in healthy women. Metab Syndr Relat Disord 2012;10:39-46.
51. Akanji AO, Smith RJ. The insulin-like growth factor system, metabolic syndrome, and cardiovascular disease risk. Metab Syndr Relat Disord 2012;10:3-13.
52. Saito K, Nagao Y, Yamashita H, et al. Screening for retinal vessel caliber and its association with metabolic syndrome in Japanese adults. Metab Syndr Relat Disord 2011;9:427-432.
53. Kalk WJ, Joffe BI, Sumner AE. The waist circumference of risk in black South African men is lower than in men of European ancestry. Metab Syndr Relat Disord 2011;9:491-495.
54. Konradi AO, Rotar OP, Korostovtseva LS, et al. Prevalence of metabolic syndrome components in a population of bank employees from St. Petersburg, Russia. Metab Syndr Relat Disord 2011;9:337-343.
55. Bonora E, Kiechl S, Zoppini G, et al. Impact of reference category and number of traits in the cluster on risk of coronary heart disease in metabolic syndrome: Prospective data from the Bruneck study. Metab Syndr Relat Disord 2011;9:313-318.
56. Malo E, Ukkola O, Jokela M, et al. Resistin is an indicator of the metabolic syndrome according to five different definitions in the Finnish health 2000 survey. Metab Syndr Relat Disord 2011;9:203-210.
57. Nichols GA, Moler EJ. Metabolic syndrome components are associated with future medical costs independent of cardiovascular hospitalization and incident diabetes. Metab Syndr Relat Disord 2011;9:127-133.
58. Sumner AE, Harman JL, Buxbaum SG, et al. The triglyceride/high-density lipoprotein cholesterol ratio fails to predict insulin resistance in African-American women: An analysis of Jackson Heart Study. Metab Syndr Relat Disord 2010;8: 511-514.
59. Chimonas T, Karagiannis A, Athyros VG, et al. Blood pressure levels constitute the most important determinant of the metabolic syndrome in a Mediterranean population: A discrimination analysis. Metab Syndr Relat Disord 2010;8: 523-529.
60. Raychaudhuri SK, Chatterjee S, Nguyen C, et al. Increased prevalence of the metabolic syndrome in patients with psoriatic arthritis. Metab Syndr Relat Disord 2010;8:331-334.
61. Esposito K, Giugliano D. Mediterranean diet and the metabolic syndrome: The end of the beginning. Metab Syndr Relat Disord 2010;8:197-200.
62. Pullinger CR, Aouizerat BE, Gay C, et al. Metabolic abnormalities and coronary heart disease risk in human immunodeficiency virus-infected adults. Metab Syndr Relat Disord 2010;8:279-286.
63. Misra A, Wasir JS, Vikram NK, et al. Cutoffs of abdominal adipose tissue compartments as measured by magnetic resonance imaging for detection of cardiovascular risk factors in apparently healthy adult Asian Indians in north India. Metab Syndr Relat Disord 2010;8:243-247.
64. AGREE Next Steps Consortium. The AGREE II Instrument. 2009. Available at http://www.agreetrust.org/index.aspx?o=1397/. Accessed December 18, 2012.
65. Brouwers MC, Kho ME, Browman GP, Burgers JS, Cluzeau F, Feder G, Fervers B, Graham ID, Grimshaw J, Hanna SE, Littlejohns P, Makarski J, Zitzelsberger L; AGREE Next Steps Consortium. AGREE II: advancing guideline development, reporting and evaluation in health care. CMAJ 2010;182:E839-842.
66. Deeks JJ, Bossuyt PM, Gatsonis C (eds). Cochrane Handbook for Systematic Reviews of Diagnostic Test Accuracy Version 1.0. The Cochrane Collaboration, 2010. Available at http://srdta.cochrane.org/. Accessed December 18, 2012.
67. Eckel RH, Alberti KGMM, Grundy SM, et al. The metabolic syndrome. Lancet 2010:375:181-183.
68. Examination Committee of Criteria for "Obesity Disease" in Japan; Japan Society for the Study of Obesity. New criteria for "obesity disease" in Japan. Circ J 2002;66:987-992.
69. Zhou BF; Cooperative Meta-Analysis Group of the Working Group on Obesity in China. Predictive values of body mass index and waist circumference for risk factors of certain related diseases in Chinese adults: Study on optimal cut-off points of body mass index and waist circumference in Chinese adults. Biomed Environ Sci 2002;15:83-96.